Literature DB >> 19818384

Actions of estrogens on glial cells: Implications for neuroprotection.

María-Angeles Arevalo1, María Santos-Galindo, María-José Bellini, Iñigo Azcoitia, Luis M Garcia-Segura.   

Abstract

Glial cells are directly or indirectly affected by estradiol and by different estrogenic compounds, such as selective estrogen receptor modulators. Acting on oligodendrocytes, astrocytes and microglia, estrogens regulate remyelination, edema formation, extracellular glutamate levels and the inflammatory response after brain injury. In addition, estradiol induces the expression and release of growth factors by glial cells that promote neuronal survival. Therefore, glial cells are important players in the neuroprotective and reparative mechanisms of estrogenic compounds.
Copyright © 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818384     DOI: 10.1016/j.bbagen.2009.10.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  78 in total

Review 1.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

2.  Role of microglia and astrocyte in central pain syndrome following electrolytic lesion at the spinothalamic tract in rats.

Authors:  Kobra Naseri; Elham Saghaei; Fatemeh Abbaszadeh; Mina Afhami; Ali Haeri; Farzaneh Rahimi; Masoumeh Jorjani
Journal:  J Mol Neurosci       Date:  2012-06-22       Impact factor: 3.444

3.  Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons.

Authors:  Rory D Spence; Amy J Wisdom; Yuan Cao; Haley M Hill; Chandler R L Mongerson; Briana Stapornkul; Noriko Itoh; Michael V Sofroniew; Rhonda R Voskuhl
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

Review 4.  Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection.

Authors:  Lucio G Costa; Rian de Laat; Khoi Dao; Claudia Pellacani; Toby B Cole; Clement E Furlong
Journal:  Neurotoxicology       Date:  2013-09-04       Impact factor: 4.294

5.  Norepinephrine regulation of ventromedial hypothalamic nucleus metabolic transmitter biomarker and astrocyte enzyme and receptor expression: Impact of 5' AMP-activated protein kinase.

Authors:  Mostafa M H Ibrahim; Hussain N Alhamami; Karen P Briski
Journal:  Brain Res       Date:  2019-01-07       Impact factor: 3.252

6.  Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis.

Authors:  Silvia Giatti; Mariaserena Boraso; Federico Abbiati; Elisa Ballarini; Donato Calabrese; Maria Santos-Galindo; Roberta Rigolio; Marzia Pesaresi; Donatella Caruso; Barbara Viviani; Guido Cavaletti; Luis Miguel Garcia-Segura; Roberto Cosimo Melcangi
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-30       Impact factor: 4.147

Review 7.  Oestrogen signalling and neuroprotection in cerebral ischaemia.

Authors:  D Brann; L Raz; R Wang; R Vadlamudi; Q Zhang
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

8.  Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI.

Authors:  Julie A Garringer; Christian Niyonkuru; Emily H McCullough; Tammy Loucks; C Edward Dixon; Yvette P Conley; Sarah Berga; Amy K Wagner
Journal:  J Neurotrauma       Date:  2013-08-15       Impact factor: 5.269

9.  Early manipulation of juvenile hormone has sexually dimorphic effects on mature adult behavior in Drosophila melanogaster.

Authors:  Kathryn J Argue; Amber J Yun; Wendi S Neckameyer
Journal:  Horm Behav       Date:  2013-09-04       Impact factor: 3.587

Review 10.  Role of estrogen treatment in the management of schizophrenia.

Authors:  Jayashri Kulkarni; Emmy Gavrilidis; Roisin Worsley; Emily Hayes
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.